Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07221123 · ClinicalTrials.gov registry record · Phase 2

Boosting Olfactory and Sensory Training Study (BOOST)

A Phase 2 study, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
Phase 2
Development phase
80
Enrollment target

NCT07221123 is a Phase 2 study that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07221123, a Phase 2 study, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
Phase 2
Development phase
80 participants
Enrollment target

Study Summary

The goal of this study is to examine two types of olfactory interventions (conventional olfactory training vs scented marker training) in adults with HIV. The two research questions are: 1. Determine if participants find the intervention acceptable and assess feasibility of the study. 2. Determine if the intervention improves olfactory function and cognitive function. Participants will come to our office and be administered the baseline battery of questions including olfactory and cognitive performance tests. Then they will be randomized and sent home with one of the two interventions (below) in which they will engage in it for 8 weeks, after which they come back to our office for the posttest battery of questions including olfactory and cognitive performance test. 1. Conventional Olfactory Training at Home -- 4 scents in which they will smell twice a day for 8 weeks. 2. Scented Marker Training at Home -- Several marker scents in which they will smell twice a day for 8 weeks.

Interventions

  • OTHER Conventional Smell Training Group
  • OTHER Scented Marker Group

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-05-02
Est. Completion 2027-12-31
Phase Phase 2

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT07221123

The ClinicalTrials.gov registry entry for NCT07221123 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Conventional Smell Training Group is the first listed.

NCT07221123 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07221123 about?

NCT07221123 is a clinical study titled "Boosting Olfactory and Sensory Training Study (BOOST)". The goal of this study is to examine two types of olfactory interventions (conventional olfactory training vs scented marker training) in adults with HIV. The two research questions are: 1. Determine if participants find the intervention acceptable and assess feasibility of the study. 2. Determine...

What is the current status of trial NCT07221123?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2026-05-02. Estimated completion is 2027-12-31.

What interventions are being tested in trial NCT07221123?

The interventions under investigation include: Conventional Smell Training Group (OTHER), Scented Marker Group (OTHER).

Who is sponsoring clinical trial NCT07221123?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.